BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21352396)

  • 21. Optical mapping of activation patterns in an animal model of congenital heart block.
    Restivo M; Kozhevnikov DO; Boutjdir M
    Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1889-95. PubMed ID: 11247806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
    Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferons and innate immune activation in autoimmune congenital heart block.
    Ambrosi A; Thorlacius GE; Sonesson SE; Wahren-Herlenius M
    Scand J Immunol; 2021 Jan; 93(1):e12995. PubMed ID: 33188653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent fetal sinus bradycardia associated with maternal anti-SSA/Ro and anti-SSB/La antibodies.
    Chockalingam P; Jaeggi ET; Rammeloo LA; Haak MC; Adama van Scheltema PN; Breur JM; Bartelings MM; Clur SA; Blom NA
    J Rheumatol; 2011 Dec; 38(12):2682-5. PubMed ID: 22089457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus.
    Buyon JP; Ben-Chetrit E; Karp S; Roubey RA; Pompeo L; Reeves WH; Tan EM; Winchester R
    J Clin Invest; 1989 Aug; 84(2):627-34. PubMed ID: 2760204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital heart block: evidence for a pathogenic role of maternal autoantibodies.
    Ambrosi A; Wahren-Herlenius M
    Arthritis Res Ther; 2012 Apr; 14(2):208. PubMed ID: 22546326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of autoantibodies to Ro(SS-A), La(SS-B) and U1RNP in different congenital heart rhythm disorders using immunoblot and enzyme immunoassay.
    Dörner T; Trebeljahr G; Göldner B; Yamamoto K; Apostoloff E; Hiepe F
    J Autoimmun; 1994 Feb; 7(1):93-106. PubMed ID: 8198704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study.
    Gerosa M; Cimaz R; Stramba-Badiale M; Goulene K; Meregalli E; Trespidi L; Acaia B; Cattaneo R; Tincani A; Motta M; Doria A; Zulian F; Milanesi O; Brucato A; Riboldi P; Meroni PL
    Rheumatology (Oxford); 2007 Aug; 46(8):1285-9. PubMed ID: 17449486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune-mediated congenital heart block.
    Wainwright B; Bhan R; Trad C; Cohen R; Saxena A; Buyon J; Izmirly P
    Best Pract Res Clin Obstet Gynaecol; 2020 Apr; 64():41-51. PubMed ID: 31685414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat model.
    Ambrosi A; Dzikaite V; Park J; Strandberg L; Kuchroo VK; Herlenius E; Wahren-Herlenius M
    Ann Rheum Dis; 2012 Mar; 71(3):448-54. PubMed ID: 22084395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.
    Sonesson SE; Hedlund M; Ambrosi A; Wahren-Herlenius M
    Rheumatology (Oxford); 2017 Oct; 56(10):1755-1762. PubMed ID: 28957562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block.
    Costedoat-Chalumeau N; Georgin-Lavialle S; Amoura Z; Piette JC
    Lupus; 2005; 14(9):660-4. PubMed ID: 16218462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases.
    Brito-Zerón P; Pasoto SG; Robles-Marhuenda A; Mandl T; Vissink A; Armagan B; Praprotnik S; Nocturne G; Sebastian A; Fernandes Moça Trevisani V; Retamozo S; Acar-Denizli N; Wiland P; Sisó-Almirall A; Bootsma H; Mariette X; Ramos-Casals M; Kostov B;
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):95-102. PubMed ID: 33025893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
    Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
    J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient heart block in a neonate associated with previously undiagnosed maternal anti-Ro/SSA and anti-La/SSB antibodies.
    Escamilla SA; Pettersen MD
    Pediatr Cardiol; 2007; 28(3):221-3. PubMed ID: 17375353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A serologic marker for fetal risk of congenital heart block.
    Salomonsson S; Dörner T; Theander E; Bremme K; Larsson P; Wahren-Herlenius M
    Arthritis Rheum; 2002 May; 46(5):1233-41. PubMed ID: 12115229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women.
    Brucato A; Frassi M; Franceschini F; Cimaz R; Faden D; Pisoni MP; Muscarà M; Vignati G; Stramba-Badiale M; Catelli L; Lojacono A; Cavazzana I; Ghirardello A; Vescovi F; Gambari PF; Doria A; Meroni PL; Tincani A
    Arthritis Rheum; 2001 Aug; 44(8):1832-5. PubMed ID: 11508435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'.
    Scarsi M; Radice A; Pregnolato F; Ramoni V; Grava C; Bianchi L; Gerosa M; Mosca M; Ghirardello A; Tani C; Motta M; Quinzanini M; Tincani A; Ruffatti A; Migliorini P; Doria A; Meroni PL; Brucato A
    Clin Exp Rheumatol; 2014; 32(6):848-54. PubMed ID: 25327946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
    Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
    Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.